Table 1.
Variable | EMR/ESD | Esophagectomy | CCRT | RT alone | p-value |
---|---|---|---|---|---|
Sex | 0.607 | ||||
Male | 57 (92) | 75 (92) | 25 (100) | 10 (100) | |
Female | 5 (8) | 7 (8) | 0 | 0 | |
Age, yr | 68 (44–82) | 64 (50–86) | 66 (55–85) | 75 (65–82) | 0.003 |
Histology | 0.834 | ||||
SCCa | 61 (98) | 81 (99) | 25 (100) | 10 (100) | |
Adenosquamous | 1 (2) | 1 (1) | 0 | 0 | |
cT stage | <0.001 | ||||
cT1a | 62 (100) | 0 | 0 | 0 | |
cT1b | 0 | 82 (100) | 25 (100) | 10 (100) | |
Tumor location | <0.001 | ||||
Cervical | 0 | 0 | 5 (20) | 1 (10) | |
Upper thoracic | 6 (10) | 10 (12) | 8 (32) | 0 | |
Middle thoracic | 17 (27) | 34 (42) | 4 (16) | 3 (30) | |
Lower thoracic | 39 (63) | 38 (46) | 8 (32) | 6 (60) |
Data are presented as number (%) or median (range).
EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; CCRT, concurrent chemoradiotherapy; RT, radiotherapy; SCCa, squamous cell carcinoma; cT stage, clinical T stage.